Velcade - Bortezomib - Velcade Myeloma - Bortezomib Myeloma


What is Velcade?

Velcade® is the first approved cancer therapy in a class of medicines known as proteasome inhibitors. In the United States, Velcade is approved by the Food and Drug Administration (FDA) for the treatment of patients with multiple myeloma.

Velcade is made by Takeda Oncology. It is also called bortezomib. Velcade is approved for use in the United States for the treatment of another type of blood cancer known as mantle cell lymphoma.

uses2 side effects2 dosing2 clinical studies2